Eventide Asset Management - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$6,546,000
-15.9%
130,0000.0%0.24%
-25.7%
Q2 2018$7,781,000
+30.7%
130,0000.0%0.32%
+15.8%
Q1 2018$5,954,000
+14.9%
130,0000.0%0.28%
+3.3%
Q4 2017$5,181,000
-0.4%
130,0000.0%0.27%
-8.5%
Q3 2017$5,200,000
-28.6%
130,000
-23.1%
0.30%
-34.9%
Q2 2017$7,284,000
-37.1%
169,000
-54.3%
0.45%
-40.9%
Q1 2017$11,581,000
+3.1%
370,000
-16.9%
0.77%
+4.9%
Q4 2016$11,236,000
+2.1%
445,0000.0%0.73%
+8.8%
Q3 2016$11,005,000
-6.0%
445,000
-22.6%
0.67%
-6.3%
Q2 2016$11,713,000
+33.6%
575,0000.0%0.72%
+46.3%
Q1 2016$8,769,000
+31.0%
575,000
+15.5%
0.49%
+46.3%
Q4 2015$6,693,000
+36.8%
498,000
+42.9%
0.34%
+18.0%
Q3 2015$4,891,000
+0.5%
348,600
+21.6%
0.28%
+8.0%
Q2 2015$4,866,000
+40.4%
286,6000.0%0.26%
+0.8%
Q1 2015$3,465,000
+62.4%
286,600
+11.5%
0.26%
+12.0%
Q4 2014$2,133,000
-4.5%
257,0000.0%0.23%
-25.3%
Q3 2014$2,233,000
-15.3%
257,000
+6.8%
0.31%
-12.8%
Q2 2014$2,635,000
+36.7%
240,600
+11.6%
0.36%
+19.7%
Q1 2014$1,927,000215,5000.30%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders